ALKS FY 2009 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$178M-45.5% YoY

Gross Profit

$129M72.3% margin

Operating Income

-$43M-24.1% margin

Net Income

-$40M-22.2% margin

EPS (Diluted)

$-0.42

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

$29M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$520M

Total Liabilities

$101M

Stockholders' Equity

$419M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$178M	$327M	-45.5%
Gross Profit	$129M	$283M	-54.5%
Operating Income	-$43M	$135M	-131.9%
Net Income	-$40M	$131M	-130.4%